Biotech stocks have struggled as a group, but the pace of drug discovery is accelerating. In this episode of “The Angle,” Sal Rais joins Jennifer Martin to explore how new ways of treating disease are improving human health and how breakthrough drugs can create value for some biotech innovators.
Year founded
Assets under management
Investment professionals
Passive investment strategies enjoyed a long period of growth in the era of low rates, ample liquidity, and low volatility that followed the global financial crisis. However, in the new world of higher rates, greater dispersion, and heightened volatility, the need for active investment strategies will increase.
Learn more about our firm and the benefits of partnering with us to meet your financial goals.
Our insights show you what’s ahead, what’s most important, and how our investment teams are responding now - so you have the full picture.
Register or sign in as an institutional investor or consultant to tailor your preferences.
Hear directly from our experts on timely themes and topics.
To view more powerful insights, connect with our team, and more!
1All data as of 31 March 2025 unless otherwise noted. Firmwide assets under management include assets managed by T. Rowe Price Associates, Inc., and its investment advisory affiliates.
Assets under management are calculated in US dollars and converted to Canadian dollars using an exchange rate determined by an independent third party.
202507-4687954